Founder of Vertice Pharma LLC, Donald W. DeGolyer presently holds the position of Secretary & Director at Vertice Pharma UK Holdings Ltd. and Secretary & Director at Vertice Pharma UK Intermediate Ltd. Mr. DeGolyer is also on the board of Tyme, Inc., Vertice Pharma LLC (former President & Chief Executive Officer), Vertice Pharma UK Parent Ltd. and HLS Therapeutics, Inc.

In his past career Donald W. DeGolyer occupied the position of Chief Operating Officer & Executive Vice President at ParkStone Medical Info Systems, Principal at Johnson & Johnson, Vice President-Marketing & Sales at Pfizer Inc., President & Chief Executive Officer of Sandoz, Inc., Chief Operating Officer for Endo Pharmaceuticals, Inc., President-Global Therapeutics at Oxford GlycoSciences Plc and SVP-Managed Markets & Established Medicines at Novartis Pharmaceuticals Corp.

Donald W. DeGolyer received an undergraduate degree from the University of Rochester and an MBA from Fairleigh Dickinson University.